ValentiLSwinkelsDWBurdickL. Serum ferritin and hepcidin levels predict vascular damage in patients with nonalcoholic fatty liver disease. Am J Hematol2009; 84: E236–E375.
3.
AkiHSFujitaMYamashitaS. Elevation of jugular venous superoxide anion radical is associated with early inflammation, oxidative stress, and endothelial injury in forebrain ischemia–reperfusion rats. Brain Res2009; 1292: 180–190.
4.
TacchiniLGammellaEDe PontiCRecalcatiSCairoG. Role of HIF-1 and NF-kB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals. J Biol Chem2008; 283: 13.
5.
AmanteaDBagettaGTassorelliCMercuriNBCorasanitiMT. Identification of distinct cellular pools of interleukin-1beta during the evolution of the neuroinflammatory response induced by transient middle cerebral artery occlusion in the brain of rat. Brain Res2010; 1313: 11.
6.
JiaJHuY-SYiWu. Pre-ischemic treadmill training affects glutamate and gamma aminobutyric acid levels in the striatal dialysate of a rat model of cerebral ischemia. Life Sci2009; 84: 7.
7.
ViatteLLesbordes-BrionJCLouDQ. Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice. Blood2005; 105: 4861–4864.
8.
NicolasGChauvetCViatteL. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest2002; 110: 1037–1044.
9.
ManolovVAtanasovaBVasilevVTzatchevKVelizarovaM. ELISA method for serum hepcidin quantification in Bulgarian population. Acta Medica Bulgarica2014; 1: 22–29.
10.
ManolovVAtanasovaBVelizarovaMVasilevVTzatchevK. Serum hepcidin levels in Bulgarian population. Clin Lab2014; 60: 2001–2006.
11.
MabjeeshNJEscuinDLaValleeTM. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell2003; 3: 13.
12.
TangWHWuSWongTMChungSKCSS. Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart. Free Radic Biol Med2008; 45: 9.
13.
HamrickSEMcQuillenPSJiangX. A role for hypoxia-inducible factor-1alpha in desferoxamine neuroprotection. Neurosci Lett2005; 379: 96–100.
